SEEQ™ Performance Study
Completed
- Conditions
- Arrhythmia Type Unknown
- Registration Number
- NCT02484898
- Lead Sponsor
- Medtronic Cardiac Rhythm and Heart Failure
- Brief Summary
The purpose of the Medtronic SEEQ™ Performance study is to build further evidence on the clinical and economic benefit of the Medtronic market-released SEEQ™ Mobile Cardiac Telemetry System/External Cardiac Monitor System (MCT/ECM).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
- Patient is indicated for a SEEQ™ MCT/ECM System for approved indications
- Patient is 18 years of age or older
- Patient is willing and able to provide consent and authorize the use and disclosure of health information
- Patient is willing and able to comply with the protocol
Exclusion Criteria
- Patient has known allergy and/or hypersensitivity to adhesives or hydrogel.
- Patient has suspected potential life-threatening arrhythmias, or requires in-subject/in-hospital monitoring.
- Patient will undergo a medical procedure that would preclude full participate during the prescribed duration of the SEEQ™
- Patient has an implanted cardiac device, (e.g., pacemaker, Implantable Cardioverter Defibrillator, Cardiac Resynchronization Therapy)
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Diagnostic Yield of the SEEQ™ MCT/ECM System 120 Days
- Secondary Outcome Measures
Name Time Method